Literature DB >> 32158318

The Relationship of SUV Value in PET-CT with Tumor Differentiation and Tumor Markers in Gastric Cancer.

Adem Maman1, Ali Sahin1, Arif Kursad Ayan2.   

Abstract

OBJECTIVE: We aimed to investigate the relationship between the use of fluoro-2-deoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT), maximized standardized uptake value (SUVmax) values of tumors, and tumor differentiation and tumor markers during the initial staging of patients with gastric cancer.
MATERIALS AND METHODS: The study included 50 patients (14 women and 36 men; mean age: 63±11 years; age range: 31-80 years) who had undergone initial staging with FDG-PET/CT after the diagnosis of gastric cancer with endoscopic biopsy between January and June 2013. Serum alpha fetoprotein (AFP), carcinogenic antigen 19-9 (CA 19.9), carcinoembryonic antigen (CEA), and C-reactive protein (CRP) levels were measured in patients prior to imaging. PET/CT images were evaluated for primary tumors, locoregional spread, and distant organ metastases, and classified by tumor-node-metastasis staging. Semiquantitative data were collected by SUVmax measurements in pathological regions of involvement. Data were analyzed statistically.
RESULTS: FDG-PET/CT showed primary gastric cancer with a sensitivity of 87%. Imaging findings were normal in 3 patients (1/3; mucinous adenocarcinoma, 2/3; signet-ring cell adenocarcinoma). With FDG-PET/CT, 3/50 patients were classified into Stage 1B, 3/50 patients into Stage 2, 5/50 patients into Stage 3A, 5/50 patients into Stage 3B, 5/50 patients into 3C and 29/50 patients into Stage 4. The mean SUVmax was calculated as 11.35±4.3 (poorly differentiated adenocarcinoma: 5.4±1.7; moderately differentiated adenocarcinoma: 10.3±4.8) for the primary tumor and 14.9±6.3 for tumor metastasis. A positive correlation was evident between the measured SUVmax and stage and the grade of primary tumor (p<0.05). While the relationship between SUVmax and levels of serum AFP and CRP was statistically significant (p<0.05), the relationship between SUVmax and levels of serum CA 19-9 and CEA was not statistically significant (p>0.05).
CONCLUSION: The SUVmax of primary tumors was associated with the degree of differentiation of primary tumors and the biochemical tumor markers CRP and AFP. The fact that SUVmax of primary tumors is high supplies clues about the presence of the factors affecting prognosis of the disease. ©Copyright 2020 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com.

Entities:  

Keywords:  FDG-PET/CT; Gastric cancer; SUVmax; initial staging; tumor markers

Year:  2020        PMID: 32158318      PMCID: PMC7051241          DOI: 10.5152/eurasianjmed.2019.19016

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  22 in total

1.  MRI in staging advanced gastric cancer: is it useful compared with spiral CT?

Authors:  A Y Kim; J K Han; C K Seong; T K Kim; B I Choi
Journal:  J Comput Assist Tomogr       Date:  2000 May-Jun       Impact factor: 1.826

2.  The role of 2-[f-18] fluoro 2-deoxy d-glucose positron emission tomography in the preoperative staging of gastric cancer.

Authors:  Kazim Duman; Abdurrahman Simsek; Semih Gorgulu; Gokhan Yagci; Yusuf Peker
Journal:  Eurasian J Med       Date:  2013-10

3.  Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.

Authors:  Takashi Yoshioka; Keiichirou Yamaguchi; Kazuo Kubota; Toshiyuki Saginoya; Tetsuro Yamazaki; Tatuo Ido; Gengo Yamaura; Hiromu Takahashi; Hiroshi Fukuda; Ryunosuke Kanamaru
Journal:  J Nucl Med       Date:  2003-05       Impact factor: 10.057

4.  Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.

Authors:  Erito Mochiki; Hiroyuki Kuwano; Hiroyuki Katoh; Takayuki Asao; Noboru Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

5.  The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer.

Authors:  Y Kodera; Y Yamamura; A Torii; K Uesaka; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

6.  Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.

Authors:  Lukas A Hefler; Nicole Concin; Gerda Hofstetter; Christian Marth; Alexander Mustea; Jalid Sehouli; Robert Zeillinger; Heinz Leipold; Harald Lass; Christoph Grimm; Clemens B Tempfer; Alexander Reinthaller
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

7.  Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.

Authors:  Dae-Weung Kim; Soon-Ah Park; Chang Guhn Kim
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

8.  Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.

Authors:  M Ychou; J Duffour; A Kramar; S Gourgou; J Grenier
Journal:  Dis Markers       Date:  2000       Impact factor: 3.434

Review 9.  PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.

Authors:  Lihu Gu; Manman Chen; Dongyu Guo; Hepan Zhu; Wenchao Zhang; Junhai Pan; Xin Zhong; Xinlong Li; Haoran Qian; Xianfa Wang
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 10.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

View more
  2 in total

1.  Preoperative prediction of the pathological stage of advanced gastric cancer by 18F-fluoro-2-deoxyglucose positron emission tomography.

Authors:  Kota Yamada; Naoki Urakawa; Shingo Kanaji; Hiroshi Hasegawa; Masashi Yamamoto; Kimihiro Yamashita; Takeru Matsuda; Taro Oshikiri; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Sci Rep       Date:  2022-07-05       Impact factor: 4.996

2.  Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions.

Authors:  Hussein Farghaly; Mohamed Alshareef; Abdullah Alqarni; Mohamed Sayed; Hatem Nasr
Journal:  Eur J Radiol Open       Date:  2020-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.